NRC Health NRC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +26.96%
- 1 year
- +81.91%
- Open
- 23.64
- Prev close
- 23.49
- Mkt cap
- 505.71M
- Vol
- 86.22K
- Avg vol
- 116.50K
- EPS
- 0.27
- P/E
- 88.26
- Div yield
- 2.80%
More statistics
- Low
- 23.47
- High
- 24.01
- Forward P/E
- 15.38
- Beta
- 0.53
- Short ratio
- 4.02
- Inst. own
- 52.02%
- Dividend
- 0.48
- Ex-div date
- Dec 26, 2024
- Earnings
- Feb 11, 2025
- 50-d avg
- 18.96
- 200-d avg
- 25.47
- 1y target
- 0.00
2Y chart
Events in this range
- Dec 27, 2024Dividend: 0.12
- Feb 11, 2025Earnings: —; estimate 0; surprise —%
- Mar 28, 2025Dividend: 0.12
- Jun 27, 2025Dividend: 0.12
- Sep 26, 2025Dividend: 0.12
- Dec 26, 2025Dividend: 0.16
- Mar 27, 2026Dividend: 0.16
- Jun 26, 2026Dividend: 0.16
- Sep 25, 2026Dividend: 0.16
Signals (100)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 29, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | May 5, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 21, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 17, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 27, 2026 | 8 months ago |
| RSI: Oversold | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| SMA: Bearish | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Jan 13, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 12, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 30, 2025 | 10 months ago |
| RSI: Overbought | Dec 16, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| RSI: Overbought | Nov 17, 2025 | 11 months ago |
| RSI: Overbought | Nov 12, 2025 | 11 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| RSI: Oversold | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 19, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 26, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 14, 2025 | 1 year ago |
| SMA: Bullish | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 7, 2025 | 1 year ago |
| RSI: Oversold | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 26, 2025 | 1 year ago |
| RSI: Overbought | Jun 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| SMA: Bullish | May 7, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 26, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 11, 2025 | 1 year ago |
| RSI: Oversold | Mar 3, 2025 | 1 year ago |
| RSI: Oversold | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 29, 2025 | 1 year ago |
| SMA: Bearish | Jan 28, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
Key statistics
- Market cap
- 418.81M
- Enterprise value
- 453.93M
- Trailing P/E
- 15.93
- Forward P/E
- 15.38
- PEG ratio
- 0.00
- Price / sales
- 2.91
- Price / book
- 12.09
- EPS (TTM)
- 1.12
- Beta
- 0.53
- Dividend yield
- 2.80%
- Payout ratio
- 42.86%
- Profit margin
- 18.79%
- Revenue (TTM)
- 144.16M
- Revenue growth
- -5.60%
- Free cash flow
- 21.74M
- Total cash
- 3.46M
- Total debt
- 54.30M
- Return on equity
- 58.56%
- Shares outstanding
- 23.48M
- Short % of float
- 2.95%
- 50-day average
- 18.96
- 200-day average
- 25.47
Analyst view
Consensus: none
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Oct 25, 2024 | Sep 1, 2024 | 0.00 | 0.24 | — | — |
| Aug 6, 2024 | Jun 1, 2024 | 0.00 | 0.26 | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | 0.27 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | 0.36 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | 0.32 | — | — |
About NRC Health
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- nrchealth.com
News
- NRC Completes Landmark Safety Review of X-energy's Xe-100 SMR
- RETRANSMISSION: Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
- Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
- Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
- National Research Q3 Earnings Call Highlights
- National Research Q3 2026 Earnings Call Transcript
- National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate
- NRC Health Announces Third Quarter 2026 Results
- NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
- NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough.
Your note
Sign in to keep a note on NRC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AMANDLA MK TRUST | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 4, 2024 | 0 |
| COMMON PROPERTY TRUST | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 29, 2024 | 0 |
| HAYS MICHAEL D | Chief Executive Officer | Conversion of Exercise of derivative security | Jan 1, 2024 | 77,090 |
| KARAS KEVIN R | Chief Financial Officer | Sale | Feb 27, 2023 | 5,384 |
| NUNNELLY JOHN N | Director | Conversion of Exercise of derivative security | Mar 26, 2024 | 32,666 |
| RAASCH JONA S | Officer | Sale | Apr 2, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 13.03% | 3,059,576 | 54.58M | Sep 29, 2024 |
| Blackrock Inc. | 4.96% | 1,164,256 | 20.77M | Sep 29, 2024 |
| Vanguard Group Inc | 4.20% | 986,370 | 17.60M | Sep 29, 2024 |
| Morgan Stanley | 3.91% | 918,757 | 16.39M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.52% | 590,797 | 10.54M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.79% | 420,733 | 7.51M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Virtus Equity Tr-Virtus KAR Small Cap Growth Fd | 8.55% | 2,008,009 | 35.82M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.51% | 589,022 | 10.51M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.58% | 371,657 | 6.63M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.04% | 243,529 | 4.34M | Sep 29, 2024 |
| DFA U.S. Micro Cap Series | 0.95% | 222,620 | 3.97M | Jul 30, 2024 |
| Fidelity Small Cap Index Fund | 0.66% | 155,361 | 2.77M | Aug 30, 2024 |